These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 2111443

  • 1. Oncogenic transformation by vrel requires an amino-terminal activation domain.
    Kamens J, Richardson P, Mosialos G, Brent R, Gilmore T.
    Mol Cell Biol; 1990 Jun; 10(6):2840-7. PubMed ID: 2111443
    [Abstract] [Full Text] [Related]

  • 2. vRel is an inactive member of the Rel family of transcriptional activating proteins.
    Richardson PM, Gilmore TD.
    J Virol; 1991 Jun; 65(6):3122-30. PubMed ID: 1903456
    [Abstract] [Full Text] [Related]

  • 3. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain.
    Sarkar S, Gilmore TD.
    Oncogene; 1993 Aug; 8(8):2245-52. PubMed ID: 8336947
    [Abstract] [Full Text] [Related]

  • 4. Temperature-sensitive transforming mutants of the v-rel oncogene.
    White DW, Gilmore TD.
    J Virol; 1993 Nov; 67(11):6876-81. PubMed ID: 8411392
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G, Gilmore TD.
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A yeast transcription assay defines distinct rel and dorsal DNA recognition sequences.
    Kamens J, Brent R.
    New Biol; 1991 Oct; 3(10):1005-13. PubMed ID: 1768648
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mutational analysis of v-rel, the oncogene of reticuloendotheliosis virus strain T.
    Bhat GV, Temin HM.
    Oncogene; 1990 May; 5(5):625-34. PubMed ID: 2189101
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular mechanisms of transformation by the v-rel oncogene.
    Hannink M, Temin HM.
    Crit Rev Oncog; 1991 May; 2(4):293-309. PubMed ID: 1958712
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
    Epinat JC, Kazandjian D, Harkness DD, Petros S, Dave J, White DW, Gilmore TD.
    Oncogene; 2000 Feb 03; 19(5):599-607. PubMed ID: 10698504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.